How does GPAT's PE Ratio compare to its peers?

GPAT is expensive based on its Price-To-Earnings Ratio (67.6x) compared to the peer average (12.5x).

How does GPAT's PE Ratio compare vs other companies in the US Capital Markets Industry?

GPAT is expensive based on its Price-To-Earnings Ratio (67.6x) compared to the US Capital Markets industry average (23.4x).

What is GPAT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate GPAT's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of GPAT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate GPAT's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

GP-Act III Acquisition (Nasdaq:GPAT) - Stock Price, News & Analysis

GPAT Stock Overview

Focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. More details

GPAT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	3/6
Financial Health	0/6
Dividends	0/6

Rewards

Became profitable this year

Risk Analysis

Makes less than USD$1m in revenue ($0)

Debt is not well covered by operating cash flow

Negative shareholders equity

GP-Act III Acquisition Corp. Competitors

Apollo Strategic Growth Capital II

NYSE:APGB

US$372.0m

ASA Gold and Precious Metals

NYSE:ASA

US$371.9m

Infinite Acquisition

NYSE:NFNT

US$373.8m

Sierra Lake Acquisition

NasdaqCM:SIER

US$379.5m

Price History & Performance

Summary of all time highs, changes and price drops for GP-Act III Acquisition
Historical stock prices
Current Share Price	US$10.08
52 Week High	US$10.10
52 Week Low	US$9.98
Beta	0
11 Month Change	0%
3 Month Change	0.40%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GPAT	US Capital Markets	US Market
7D	0%	-0.4%	-2.1%
1Y	n/a	55.1%	29.7%

Return vs Industry: Insufficient data to determine how GPAT performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how GPAT performed against the US Market.

Price Volatility

Is GPAT's price volatile compared to industry and market?
GPAT volatility
GPAT Average Weekly Movement	0.3%
Capital Markets Industry Average Movement	3.9%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GPAT has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GPAT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2020	n/a	Antonio Carlos Augusto Bonchristiano	www.gp-act3.com

GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

GP-Act III Acquisition Corp. Fundamentals Summary

How do GP-Act III Acquisition's earnings and revenue compare to its market cap?
GPAT fundamental statistics
Market cap	US$362.25m
Earnings (TTM)	US$5.36m
Revenue (TTM)	n/a

67.6x

P/E Ratio

0.0x

P/S Ratio

Is GPAT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GPAT income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	-US$5.36m
Earnings	US$5.36m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.15
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	-2.9%

How did GPAT perform over the long term?

See historical performance and comparison